A Double-Blind, Randomized, Placebo-Controlled Phase 3 Noninferiority Study of Darbepoetin Alfa for Anemia in Advanced NSCLC

被引：3

作者：

Nagarkar, R. ^{[1
]}

Gascon, P. ^{[2
]}

Smakal, M. ^{[3
]}

Syrigos, K. ^{[4
]}

Barrios, C. ^{[5
]}

Cardenas Sanchez, J. ^{[6
]}

Zhang, L. ^{[7
]}

Tomita, D. ^{[8
]}

Park, J. ^{[8
]}

Brandao, C. De Oliveira ^{[8
]}

机构：

[1] Curie Manavata Canc Ctr, Nasik, Maharashtra, India

[2] Barcelona Univ, Hosp Clin, Barcelona, Spain

[3] Nh Hosp AS, Nemocn Horovice, Horovice, Czech Republic

[4] Athens Sch Med, Dept Med 3, Athens, Greece

[5] Hosp Canc Mae Deus, Med Oncol, Porto Alegre, RS, Brazil

[6] Ctr Med Colima, Colima, Mexico

[7] Sun Yat Sen Univ, Canc Ctr, East Guangzhou, Peoples R China

[8] Amgen Inc, Thousand Oaks, CA 91320 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期

关键词：

overall survival; darbepoetin alfa; chemotherapy-induced anemia;

D O I：

10.1016/j.jtho.2018.08.325

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MA02.05

引用

页码：S359 / S359

页数：1

共 50 条

[31] Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regiments of darbepoetin alfa in patients with heart failure and anaemia: reply
van Veldhuisen, Dirk J.
Wasserman, Scott M.
Baker, Nigel
EUROPEAN HEART JOURNAL, 2008, 29 (04) : 566 - 567
[32] Fostamatinib treatment of warm antibody autoimmune hemolytic anemia: a global, randomized, double-blind, placebo-controlled, phase 3 study
Cooper, Nichola
Numerof, Robert
Stacey, Duncan
Tong, Sandra
Kuter, David
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 63 - 63
[33] Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double-blind, placebo-controlled, global study (FORWARD)
Kuter, David J.
Piatek, Caroline
Roth, Alexander
Siddiqui, Asif
Numerof, Robert P.
Dummer, Wolfgang
FORWARD study grp
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (01) : 79 - 87
[34] Talactoferrin Alfa Reduces Mortality In Severe Sepsis: Results Of A Phase 2 Randomized, Placebo-controlled, Double-blind Study
Guntupalli, K. K.
Dean, N. C.
Morris, P. E.
Bandi, V.
Margolis, B. D.
Rivers, E.
Levy, M. M.
Lodato, R. F.
Schaumberg, J.
Malik, R. K.
Dellinger, P.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
[35] PLACEBO-CONTROLLED, RANDOMIZED, DOUBLE-BLIND STUDY OF INCOBOTULINUMTOXINA FOR SIALORRHEA
Jost, W.
Friedman, A.
Michel, O.
Oehlwein, C.
Slawek, J.
Bogucki, A.
Ochudlo, S.
Banach, M.
Pagan, F.
Flatau-Baque, B.
Csikos, J.
Cairney, C. J.
Blitzer, A.
PARKINSONISM & RELATED DISORDERS, 2023, 113 : 40 - 40
[36] A Randomized, Masked, Placebo-Controlled Study of Darbepoetin Alfa in Preterm Infants
Ohls, Robin K.
Christensen, Robert D.
Kamath-Rayne, Beena D.
Rosenberg, Adam
Wiedmeier, Susan E.
Roohi, Mahshid
Lacy, Conra Backstrom
Lambert, Diane K.
Burnett, Jill J.
Pruckler, Barbara
Schrader, Ron
Lowe, Jean R.
PEDIATRICS, 2013, 132 (01) : E119 - E127
[37] CETACAINE EFFICACY - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
LACHTER, J
JACOBS, R
LAVY, A
SUISSA, A
WEISLER, A
EIDELMAN, S
GASTROENTEROLOGY, 1988, 94 (05) : A245 - A245
[38] Anlotinib as 3rd-Line Treatment for Refractory Advanced NSCLC: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
Han, Baohui
Li, Kai
Zhao, Yizuo
Li, Baolan
Cheng, Ying
Zhou, Jianying
Lu, You
Shi, Yuankai
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S177 - S177
[39] Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia
Ghali, Jalal K.
Anand, Inder S.
Abraham, William T.
Fonarow, Gregg C.
Greenberg, Barry
Krum, Henry
Massie, Barry M.
Wasserman, Scott M.
Trotman, Marie-Louise
Sun, Yan
Knusel, Beat
Armstrong, Paul
CIRCULATION, 2008, 117 (04) : 526 - 535
[40] Randomized, Double-Blind, Placebo-Controlled Trial of Epoetin Alfa in Men With Castration-Resistant Prostate Cancer and Anemia
Winquist, Eric
Julian, Jim A.
Moore, Malcolm J.
Nabid, Abdenour
Sathya, Jinka
Wood, Lori
Venner, Peter
Levine, Mark
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) : 644 - 646

← 1 2 3 4 5 →